Breast Cancer Clinical Trial
Official title:
Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses - A Pilot Stdy
The purpose of this study is to focus on dyadic coping as one of the main factors that
enhance resilience in adjustment to cancer, while also assessing other protective factors
for coping with traumatic events.
Specifically, the study aims are:
1. To assess the level of post traumatic distress, functional impairment and depression
among breast and prostate cancer patients and their spouses.
2. To assess resiliency factors such as flexibility, self efficacy and ego resilience
among breast and prostate cancer patients and their spouses.
3. To examine the pattern of dyadic coping at 3 time points: at the beginning and end of
radiation therapy, and at six-week follow-up.
4. To examine the relationships between dyadic coping and level of posttraumatic distress
and the resilience factors over time (in 3 repeated measures) Different aspects of
coping with the trauma of cancer and its treatment may be assessed. Measures of
strength and distress amongst patients and their spouses may enable a fuller picture of
what types of responses exist, which interventions may be most beneficial, and what
other factors may relate to positive coping, increased resilience and quality of life,
such as flexibility, and the nature of the couples' dyadic coping.
Introduction:
In the proposed study, we will investigate the risk and protective factors for healthy
coping amongst breast and prostrate cancer patients and their spouses. A special focus will
be on dyadic coping patterns, i.e. how do the coping patterns of the patient and his/her
spouse correlate and how does the spousal response facilitate or impede the outcome of
coping of the patient.
Different aspects of coping with the trauma of cancer and its treatment may be assessed.
Measures of strength and distress amongst patients and their spouses may enable a fuller
picture of what types of responses exist, which interventions may be most beneficial, and
what other factors may relate to positive coping, increased resilience and quality of life,
such as flexibility, and the nature of the couples' dyadic coping.
All new incoming married patients to the Institute of Radiotherapy at the Tel Aviv
(Sourasky) Medical Center from September to January, 2007 will be presented with the request
to participate in this research. Overall, we plan to recruit 40 breast and prostate cancer
patients and their spouses.
Measures:
1. Demographic and medical questionnaire (adapted to the type of illness).
2. Exposure to trauma. Participants' exposure to possible traumatic events was assessed by
The Trauma History Scale created by Pat-Horenczyk in 2004 based on the Posttraumatic
Diagnostic Scale (PDS) by Foa, Cashman, Jaycox, and Perry (1997).
3. Posttraumatic Stress Diagnostic Scale (PDS). A self-report assessment that meets all
the criteria of the DSM-IV for diagnosis of PTSD developed by Foa, Cashman, Jaycox &
Perry, 1997).
4. Depression questionnaire (CESD, The Centre For Epidemiological Studies Depression Scale
(CES-D).
5. Flexibility Questionnaire: The Flexibility Scale was developed by Bonanno and
Pat-Horenczyk in (2006) and translated into Hebrew.
6. Dyadic coping : The quality of adjustment in the marital relationship will be measured
using the Dyadic Adjustment Scale (DAS). This 32 item measure is widely used in
clinical and research settings and consists of four subscales: Dyadic Consensus, Dyadic
Satisfaction, Dyadic Cohesion and Affectional Expression.
7. Self efficacy: The GSE (General perceived self efficacy scale) was developed by
Zeidner, Jerusalem & Schwarzer (1993) and includes 10 items which measure positive self
statements with regards to a variety of coping requirements.
8. Ego Resilience: The short 14 item version of Ego-Resiliency Scale was presented in 1996
by Block & Kremen (1996).
Procedure:
Physicians working at the Institute of Radiotherapy at the Tel Aviv (Sourasky) Medical
Center will inform all potential participants about the purpose of the study. Those who show
interest and match the inclusion criteria will be asked to sign the informed consent with
the doctor, who will provide more detailed information. The research assistant will set up a
meeting at the Medical Center with the each interested couple (individually with each
couple) to fill out the questionnaires. The approximate time for filling out the entire
battery is 30 minutes. In order to participate, both patients and their spouses must agree
to fill out the questionnaires at the three time points.
In the informed consent it will be specified that participants who may experience distress
following the questionnaire or as a result of the research will be offered short individual
or couple counseling as needed by the psychosocial staff of the Institute of Radiotherapy.
;
Observational Model: Defined Population, Time Perspective: Longitudinal
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |